These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 6375076

  • 1. Clinical pharmacokinetics of estramustine phosphate.
    Gunnarsson PO, Forshell GP.
    Urology; 1984 Jun; 23(6 Suppl):22-7. PubMed ID: 6375076
    [No Abstract] [Full Text] [Related]

  • 2. Metabolic parameters of Estracyt pertinent to its effects in prostatic cancer.
    Sandberg AA.
    Urology; 1984 Jun; 23(6 Suppl):11-21. PubMed ID: 6375075
    [No Abstract] [Full Text] [Related]

  • 3. Metabolism of estramustine phosphate (Estracyt) in patients with prostatic carcinoma.
    Andersson SB, Gunnarsson PO, Nilsson T, Forshell GP.
    Eur J Drug Metab Pharmacokinet; 1981 Jun; 6(2):149-54. PubMed ID: 7274309
    [Abstract] [Full Text] [Related]

  • 4. Specific binding of estramustine to prostatic proteins.
    Forsgren B, Björk P.
    Urology; 1984 Jun; 23(6 Suppl):34-8. PubMed ID: 6375077
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of estramustine phosphate (Estracyt) in prostatic cancer patients.
    Gunnarsson PO, Andersson SB, Johansson SA, Nilsson T, Plym-Forshell G.
    Eur J Clin Pharmacol; 1984 Jun; 26(1):113-9. PubMed ID: 6714283
    [Abstract] [Full Text] [Related]

  • 6. Estramustine phosphate: metabolic aspects related to its action in prostatic cancer.
    Kadohama N, Kirdani RY, Murphy GP, Sandberg AA.
    J Urol; 1978 Feb; 119(2):234-9. PubMed ID: 633484
    [Abstract] [Full Text] [Related]

  • 7. The absorption metabolism, and excretion of Estracyt (NSC 89199) in patients with prostatic cancer.
    Forshell GP, Müntzing J, Ek A, Lindstedt E, Dencker H.
    Invest Urol; 1976 Sep; 14(2):128-31. PubMed ID: 972005
    [Abstract] [Full Text] [Related]

  • 8. Plasma concentrations of estramustine phosphate and its major metabolites in patients with prostatic carcinoma treated with different doses of estramustine phosphate (Estracyt).
    Gunnarsson PO, Forshell GP, Fritjofsson A, Norlén BJ.
    Scand J Urol Nephrol; 1981 Sep; 15(3):201-5. PubMed ID: 7323739
    [Abstract] [Full Text] [Related]

  • 9. Estramustine. Metabolic pattern and possible mechanisms for its action in prostate cancer.
    Kadohama N, Kirdani RY, Madajewicz S, Murphy GP, Sandberg AA.
    N Y State J Med; 1979 Jun; 79(7):1005-9. PubMed ID: 287893
    [No Abstract] [Full Text] [Related]

  • 10. [Estracyt (estradiol-nitrogen mustard complex)--estramustine binding protein and its specificity].
    Yamanaka H, Imai K, Suzuki T, Yuasa H, Takahashi E.
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2106-14. PubMed ID: 6486830
    [Abstract] [Full Text] [Related]

  • 11. Metabolic aspects and actions unique to Estracyt.
    Sandberg AA.
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):3-15. PubMed ID: 6364364
    [No Abstract] [Full Text] [Related]

  • 12. Binding characteristics of a major protein in rat ventral prostate cytosol that interacts with estramustine, a nitrogen mustard derivative of 17 beta-estradiol.
    Forsgren B, Gustafsson JA, Pousette A, Högberg B.
    Cancer Res; 1979 Dec; 39(12):5155-64. PubMed ID: 40694
    [Abstract] [Full Text] [Related]

  • 13. [Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt"].
    Yamanaka H, Shida K.
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):537-44. PubMed ID: 6422861
    [Abstract] [Full Text] [Related]

  • 14. Inhibition by estramustine phosphate on estradiol and androgen binding in benign and malignant prostate in humans.
    Nilsson I, Liskowski L, Nilsson T.
    Urology; 1976 Aug; 8(2):118-21. PubMed ID: 60819
    [Abstract] [Full Text] [Related]

  • 15. Subcellular localization of estramustine in rat ventral prostate following intravenous injection.
    Peterson C, Forsgren B, Högberg B.
    Acta Physiol Scand Suppl; 1983 Aug; 515():55-63. PubMed ID: 6578672
    [No Abstract] [Full Text] [Related]

  • 16. Prostate cancer; plasma concentrations of estramustine phosphate and its metabolites.
    Kirdani RY, Karr JP, Murphy GP, Sandberg AA.
    N Y State J Med; 1980 Aug; 80(9):1390-3. PubMed ID: 6938806
    [No Abstract] [Full Text] [Related]

  • 17. Autoradiographic studies of 3H-estramustine in the rat ventral prostate.
    Appelgren LE, Forsgren B, Gustafsson JA, Pousette A, Högberg B.
    Acta Pharmacol Toxicol (Copenh); 1978 Nov; 43(5):368-74. PubMed ID: 726901
    [Abstract] [Full Text] [Related]

  • 18. The hydrolysis of estramustine phosphate; in vitro studies.
    Gunnarsson O, Andersson SB, Johansson SA.
    Eur J Drug Metab Pharmacokinet; 1983 Nov; 8(4):395-402. PubMed ID: 6673977
    [Abstract] [Full Text] [Related]

  • 19. A time study on the uptake of estramustine into prostatic tumour 1013L cells in vitro.
    Kruse E, Hartley-Asp B.
    Biochem Pharmacol; 1989 Feb 15; 38(4):702-4. PubMed ID: 2917024
    [No Abstract] [Full Text] [Related]

  • 20. Studies on a nitrogen mustard of estradiol in dogs and rats.
    Kirdani RY, Murphy GP, Sandberg AA.
    Proc Soc Exp Biol Med; 1977 May 15; 155(1):94-8. PubMed ID: 859886
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.